Kadmon Holdings LLC Stock News

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Jefferies 2020 Virt

The company reported positive results from a clinical trial for one of its most promising pipeline candidates.

The New York-based biotech said it intends to submit to the Food and Drug Administration in October, taking advantage of an agency pilot program.

NEW YORK, NY / ACCESSWIRE / May 21, 2020 / Kadmon Holdings, Inc. (KDMN) today announced positive topline results from the primary analysis of ROCKstar (KD025-213), the pivotal trial evaluating belumos

Bull market or bear market, one fact remains unwavering: Biotech stocks represent the ultimate risk/reward plays.These investments are inherently volatile in nature. Numerous biotechnology companies h

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Kadmon Holdings (NYSE:KDMN) on Monday, setting a price target of $25, which is approximately 470.78% above the present share price of $4.

Shareholders of Kadmon Holdings, Inc. (NYSE:KDMN) will be pleased this week, given that the stock price is up 10% to...

NEW YORK, NY / ACCESSWIRE / May 7, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today provided a business update and reported financial and operational results for the first quarter of 2020. "We made ...

Bank of New York Mellon Corp grew its holdings in Kadmon Holdings Inc (NYSE:KDMN) by 27.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm own

Janssen signed a collaboration with ImmunoPrecise Antibodies Ltd. Kadmon will file an NDA for its GVHD drug. Pfenex suffered a regulatory setback.

Harlan Waksal became the CEO of Kadmon Holdings, Inc. (NYSE:KDMN) in 2014. First, this article will compare CEO...

NEW YORK, NY / ACCESSWIRE / April 14, 2020 / Kadmon Holdings, Inc. (KDMN) today announced that it has received the final meeting minutes from the U.S. Food and Drug Administration (FDA) following its

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR) and Kadmon Holdings

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.